All Journals > Clinical Infectious Diseases > 15 September 2005 > GBS Infection in Elderly Adults

Article Tools

Search for Related Articles

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

15 September 2005

Volume 41, Number 6
Clinical Infectious Diseases 2005;41:839–847
1058-4838/2005/4106-0014$15.00
DOI: 10.1086/432804
AGING AND INFECTIOUS DISEASES INVITED ARTICLE

Group B Streptococcal Infections in Elderly Adults

Morven S. Edwards1 and

Carol J. Baker1,2

Section of Infectious Disease, Departments of 1Pediatrics and 2Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas

Elderly adults account for >40% of persons with invasive group B streptococcal (GBS) disease and for >50% of GBS‐associated deaths in the United States. The prevalence of colonization among healthy elderly adults (25%) is similar to that among women of childbearing age. Delineating contributions of comorbid conditions, altered integrity of anatomical barriers, and abnormalities in immune responses caused by immune senescence to pathogenesis require further investigation. Delayed clinical recognition of illness may contribute to poor outcome. Skin and soft‐tissue infections and bacteremia with no identified focus are common manifestations of infection in elderly adults and younger nonpregnant adults. Urinary tract infection and pneumonia are presentations more often encountered in elderly persons than in younger adults. The safety and immunogenicity of GBS serotype V–tetanus toxoid conjugate vaccine in healthy elderly persons suggest the potential for vaccination as an approach to prevention of invasive GBS infections in elderly persons.

Received 4 May 2005; accepted 30 May 2005; electronically published 16 August 2005.

Reprints or correspondence: Dr. Morven S. Edwards, Dept. of Pediatrics, Section of Infectious Diseases, Rm. 302A, Baylor College of Medicine, Houston, TX 77030 ().

Kevin P. High, Section Editor

Cited by

Isabella Santi, Domenico Maione, Cesira L. Galeotti, Guido Grandi, John L. Telford, and Marco Soriani. (2009) BibA Induces Opsonizing Antibodies Conferring In Vivo Protection against Group B Streptococcus. The Journal of Infectious Diseases 200:4, 564-570
Online publication date: 15-Aug-2009.
Tami H. Skoff, Monica M. Farley, Susan Petit, Allen S. Craig, William Schaffner, Ken Gershman, Lee H. Harrison, Ruth Lynfield, Janet Mohle‐Boetani, Shelley Zansky, Bernadette A. Albanese, Karen Stefonek, Elizabeth R. Zell, Delois Jackson, Terry Thompson, and Stephanie J. Schrag. (2009) Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007. Clinical Infectious Diseases 49:1, 85-92
Online publication date: 1-Jul-2009.
S. Rantala, J. Vuopio-Varkila, R. Vuento, H. Huhtala, J. Syrjänen. (2009) Clinical presentations and epidemiology of β-haemolytic streptococcal bacteraemia: a population-based study. Clinical Microbiology and Infection 15:3, 286-288
Online publication date: 1-Apr-2009.
CrossRef
H. Bergseng, M. Rygg, L. Bevanger, K. Bergh. (2009) Invasive group B streptococcus (GBS) disease in Norway 1996–2006. European Journal of Clinical Microbiology & Infectious Diseases 27:12, 1193-1199
Online publication date: 1-Jan-2009.
CrossRef
Heather C. Maisey, Kelly S. Doran, Victor Nizet. (2008) Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Reviews in Molecular Medicine 10,
Online publication date: 1-Oct-2008.
CrossRef
I. C. Sutcliffe, G. W. Black, D. J. Harrington. (2008) Bioinformatic insights into the biosynthesis of the Group B carbohydrate in Streptococcus agalactiae. Microbiology 154:5, 1354-1363
Online publication date: 1-Jun-2008.
CrossRef
P. Sendi, L. Johansson, A. Norrby-Teglund. (2008) Invasive Group B Streptococcal Disease in Non-pregnant Adults. Infection
Online publication date: 12-Feb-2008.
CrossRef
Jason N. Cole, Anna Henningham, Christine M. Gillen, Vidiya Ramachandran, Mark J. Walker. (2008) Human pathogenic streptococcal proteomics and vaccine development. PROTEOMICS – Clinical Applications 2:3, 387
CrossRef
Atul Kumar Johri, Lawrence C Paoletti, Philippe Glaser, Meenakshi Dua, Puja Kumari Sharma, Guido Grandi, Rino Rappuoli. (2007) Group B Streptococcus: global incidence and vaccine development. Nature Reviews Microbiology 4:12, 932-942
Online publication date: 1-Jan-2007.
CrossRef
Close Popup